Application Notes

Cellastim S – Reconstitution Application Note

rHSA Reconstitution Video Protocol

Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note

Reducing Serum-Associated Contaminants from Growth Media in Primary Cell Culture

Blog

Controlling Impurities in Cell Culture Media

Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease

SARS-CoV2 and Influenza – Double Threat

The Emergence of Serum-Free Cell Culture Media – Blood-Free Chemically Defined Components

Interviews

Blood-Free Fetal Bovine Serum Alternatives in Cell Culture Media

Journal Articles (DOI Links)

Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes

Accurate nanoelectrode recording of human pluripotent cell-derived cardiomyocytes for assaying drugs and modeling disease

Improvements in Viral Vector Manufacturing Process with Chemical Definition of Cell Culture Media & Excipients

Posters

Adherent HEK293t Cells Cultured in Pall’s iCELLis® Bioreactor with OptiPEAK HEK293t Blood-Free Chemically Defined Media Exhibit Robust and Rapid Population Doubling Times

Product Brochures

2021 Product Catalog

ITSE AF – Brochure

Optiferrin – Product Brochure

Product Specifications

ITS – Specifications

SDS

Exbumin – Safety Data Sheet

ITSE AF – Safety Data Sheet

Optibumin – Safety Data Sheet

Use Guidelines

Cellastim S – Guidelines for Use

Exbumin – Guidelines for Use

ITS – Guidelines for Use

ITSE AF – Guidelines for Use

ITSE+A – Guidelines for Use

Optiferrin – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Emergence of Blood-Free Recombinant Human Albumin